The Montreal cancer-drug developer increased its share-price range from US$18 to US$20, up from a Monday range of US$16 to US$18. (The Globe and Mail)
Skip to content
The Montreal cancer-drug developer increased its share-price range from US$18 to US$20, up from a Monday range of US$16 to US$18. (The Globe and Mail)
Talking point: This is the second time Repare has increased the size of its Nasdaq listing. On May 29, the firm announced plans to bring in US$100 million. Over the past week, the share prices of two California biotech firms—Vaxcyte and Avidity Biosciences—increased by 50 per cent or more on their first trading day. Repare is the latest Canadian biotech firm to go public on the Nasdaq. Three went public or cross-listed on it last year. Hamilton, Ont.-based Fusion Pharmaceuticals and Vancouver- and Seattle-based Chinook Therapeutics are both currently seeking Nasdaq listings.
Loading...
Thanks for sharing!
You have shared 5 articles this month and reached the maximum amount of shares available.
CloseThis account has reached its share limit.
If you would like to purchase a sharing license please contact The Logic support at [email protected].
CloseGift the full article!
You have gifted 0 article(s) this month and have 5 remaining.
Recipients will be able to read the full text of the article after submitting their email address. They will not have access to other articles or subscriber benefits.
Most Popular This Week
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
News
What makes a nuclear reactor Canadian? Billions of dollars ride on the answer
Briefing
Trump administration tries to speed up quantum development, defences
Shopify to ban vapes from U.S. shops
Ballard to buy U.K.’s GeoPura for US$400M
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
Exclusive events
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.
